Further Concerns About Glutamine: A Case Report on Hyperammonemic Encephalopathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26035146.
- Also identified by DOI 10.1097/CCM.0000000000001151.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of a woman with hyperammonemic encephalopathy following glutamine supplementation. Case report. Plasma amino acid analysis suggestive of a urea cycle defect and initiation of a treatment with lactulose and the two ammonia scavenger drugs sodium benzoate and phenylacetate. Together with a restricted protein intake ammonia and glutamine plasma levels decreased with subsequent improvement of the neurological status. Massive catabolism and exogenous glutamine administration may have contributed to hyperammonemia and hyperglutaminemia in this patient. This case adds further concerns regarding glutamine administration to critically ill patients and implies the importance of monitoring ammonia and glutamine serum levels in such patients.
Medical subject headings
- Brain Diseases, Metabolic
- Dietary Supplements
- Glutamine
- Hyperammonemia